National Center for Advancing Translational Sciences in Washington
National Center for Advancing Translational Sciences (93.350) awarded $81.5 million to recipients in Washington in 20 grants from fiscal 2021 to 2025, 2.6% of the program's national total. University of Washington received the most, $66.1 million.
- Awarded in Washington$81.5 million
- Awards20
- Share of the program2.6%
- Rank among states11th of 41
- National total$3.1 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 10 | $19.2 million |
| FY 2022 | 9 | $16.7 million |
| FY 2023 | 9 | $14.8 million |
| FY 2024 | 9 | $15.5 million |
| FY 2025 | 7 | $15.3 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Washington | Colleges and universities | 9 | $66.1 million |
| Curi Bio Inc | Small businesses | 2 | $4.4 million |
| Sound Pharmaceuticals Inc. | Small businesses | 1 | $4.2 million |
| Seattle Children's Hospital | Nonprofits | 3 | $2.9 million |
| Talus Bioscience Inc | Small businesses | 2 | $2.3 million |
| Nortis Inc | Small businesses | 1 | $1.0 million |
| Monod Bio, Inc. | Small businesses | 1 | $290,066 |
| Precision Quantomics, Inc. | Small businesses | 1 | $285,444 |
Open opportunities under this program
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Clinical and Translational Science Award (UM1 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
See all 34 on the program page
Questions people ask
How much National Center for Advancing Translational Sciences money goes to Washington?
$81.5 million from fiscal 2021 to 2025, across 20 awards. Washington ranks 11th of 41 states and territories for this program.
Who receives National Center for Advancing Translational Sciences money in Washington?
The largest recipient is University of Washington, with $66.1 million in 9 awards. Next are Curi Bio Inc and Sound Pharmaceuticals Inc..
Can organizations in Washington apply now?
Yes, 34 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
National Center for Advancing Translational Sciences in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant